Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133920) titled 'A Study on the Association between Gut Microbiota Dysbiosis, Intestinal Barrier Function and Intestinal Metabolites in Patients with Vascular-Metabolic Ejection Fraction-Preserved Heart Failure, and Their Clinical Phenotypes and Short- to Medium-Term Prognosis' on Oct. 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The first hospital of Shanxi Medical University
Condition:
Disorders of the gastrointestinal microenvironment, impairment of the mucosal barrier and associated diseases
heart failure with preserved ejection fraction
Intervention:
Vascular-metabolic HFpEF group:Non...